Trust Point Inc. Has $231,000 Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Trust Point Inc. cut its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 56.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,607 shares of the company's stock after selling 3,428 shares during the quarter. Trust Point Inc.'s holdings in U.S. Physical Therapy were worth $231,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets boosted its stake in shares of U.S. Physical Therapy by 283.0% in the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company's stock valued at $1,425,000 after buying an additional 12,445 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in U.S. Physical Therapy by 57.1% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company's stock valued at $223,000 after acquiring an additional 956 shares in the last quarter. State Street Corp lifted its position in shares of U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company's stock valued at $56,522,000 after acquiring an additional 99,244 shares during the period. Stifel Financial Corp grew its holdings in shares of U.S. Physical Therapy by 12.1% during the 3rd quarter. Stifel Financial Corp now owns 57,166 shares of the company's stock worth $4,838,000 after purchasing an additional 6,154 shares in the last quarter. Finally, Harbor Capital Advisors Inc. raised its stake in U.S. Physical Therapy by 113.4% in the third quarter. Harbor Capital Advisors Inc. now owns 16,188 shares of the company's stock valued at $1,370,000 after purchasing an additional 8,604 shares in the last quarter.

Insider Buying and Selling

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the business's stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the sale, the chief financial officer now directly owns 20,469 shares of the company's stock, valued at $1,970,141.25. The trade was a 2.46 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of the firm's stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total transaction of $185,900.00. Following the transaction, the director now directly owns 16,726 shares of the company's stock, valued at $1,554,681.70. The trade was a 10.68 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock opened at $87.72 on Friday. The company's 50 day moving average price is $91.29 and its two-hundred day moving average price is $88.51. The firm has a market capitalization of $1.32 billion, a P/E ratio of 93.32, a P/E/G ratio of 3.65 and a beta of 1.48. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. U.S. Physical Therapy, Inc. has a fifty-two week low of $76.18 and a fifty-two week high of $113.63.

Analyst Ratings Changes

A number of brokerages have issued reports on USPH. JPMorgan Chase & Co. increased their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Tuesday, December 3rd. JMP Securities assumed coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They issued an "outperform" rating and a $113.00 price objective on the stock. Barrington Research restated an "outperform" rating and set a $108.00 target price on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. Bank of America raised U.S. Physical Therapy from a "neutral" rating to a "buy" rating and raised their target price for the company from $100.00 to $115.00 in a report on Monday, December 16th. Finally, Citizens Jmp raised U.S. Physical Therapy to a "strong-buy" rating in a report on Monday, December 16th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Buy" and an average target price of $114.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.